Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells.
Effect of lipoic acid consumption on oxidative stress among multiple sclerosis patients: A randomized controlled clinical trial.
Mitochondrial approaches for neuroprotection.
Epigenetic mechanisms in multiple sclerosis and the major histocompatibility complex (MHC).
Epidemiology of multiple sclerosis in Australia. With NSW and SA survey results.
A high-density screen for linkage in multiple sclerosis.
BRIEF-AB Science says DSMB recommends continuation of phase 3 masitinib study
Phase 2 BOLD extension study efficacy results for siponimod (BAF312) in patients with relapsing-remitting multiple sclerosis.
Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship.
Circulating monocytes are reduced by sphingosine-1-phosphate receptor modulators independently of S1P3.
US top court denies Israel's Teva Pharmaceuticals stay in Copaxone patent fight
Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial.
Substance Name: Amiloride
Durable pharmacological responses from the peptide drug ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease.
Receptos Reports Positive Phase 2 Results for TOUCHSTONE Trial of RPC1063 in Ulcerative Colitis
Prolonged Remission in Neuromyelitis Optica Following Cessation of Rituximab Treatment.
Regional Susceptibility to TNF-α Induction of Murine Brain Inflammation via Classical IKK/NF-κB Signalling.
Guillain-Barré syndrome-like-onset neurosarcoidosis positive for immunoglobulin G anti-N-acetylgalactosaminyl-GD1a antibody.
Food and Drug Administration Approval Letter for Alemtuzumab
Potassium-Retaining Diuretics: Amiloride
MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial
Prevention and treatment of MS: studying the effects of vitamin D.
Stress signaling etches heritable marks on chromatin.
Cluster-tic syndrome as the initial manifestation of multiple sclerosis.
Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis.

Pages